VALIDATION OF KMO AS A CANDIDATE THERAPEUTIC TARGET FOR HUNTINGTON'S DISEASE IN DROSOPHILA MELANOGASTER

被引:0
|
作者
Campesan, S. [1 ]
Green, E. W. [1 ]
Sathyasaikumar, K. V. [2 ]
Breda, C. [1 ]
Muchowski, P. J. [3 ,4 ,5 ]
Schwarcz, R. [2 ]
Kyriacou, C. P. [1 ]
Giorgini, F. [1 ]
机构
[1] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England
[2] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Baltimore, MD 21201 USA
[3] Univ Calif San Francisco, Gladstone Inst Neurol Dis, Dept Biochem, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Gladstone Inst Neurol Dis, Dept Biophys, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Gladstone Inst Neurol Dis, Dept Neurol, San Francisco, CA 94143 USA
关键词
D O I
10.1136/jnnp.2010.222596.6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:A12 / A13
页数:3
相关论文
共 50 条
  • [1] Validation of candidate therapeutic targets for Huntington's disease in drosophila
    Campesan, S.
    Kyriacou, C. P.
    Giorgini, F.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 : A5 - A6
  • [2] IDENTIFICATION AND VALIDATION OF CANDIDATE THERAPEUTIC TARGETS FOR HUNTINGTON'S DISEASE
    Clapp, J.
    Giorgini, F.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 : A11 - A11
  • [3] Modelling Huntington disease in Drosophila melanogaster
    Doumanis, Joanna
    Kazama, Ritsuko
    Moore, Adrian
    Nukina, Nobuyuki
    [J]. NEUROSCIENCE RESEARCH, 2006, 55 : S256 - S256
  • [4] The Tiny Drosophila Melanogaster for the Biggest Answers in Huntington's Disease
    Rosas-Arellano, Abraham
    Estrada-Mondragon, Argel
    Pina, Ricardo
    Mantellero, Carola A.
    Castro, Maite A.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (08)
  • [5] Neuroinflammation as a therapeutic target in Huntington's disease
    Andrea Kwakowsky
    Thulani H.Palpagama
    [J]. Neural Regeneration Research, 2025, (03) : 817 - 818
  • [6] Developing a transgenic marker to research Huntington's disease in Drosophila melanogaster
    Rodney, Simon
    Imarisio, S.
    [J]. INTERNATIONAL JOURNAL OF COLLABORATIVE RESEARCH ON INTERNAL MEDICINE & PUBLIC HEALTH, 2010, 2 (06) : 199 - 213
  • [7] Quality Control in Huntington’s Disease: a Therapeutic Target
    Sachchida Nand Rai
    Brijesh Kumar Singh
    Aaina Singh Rathore
    Walia Zahra
    Chetan Keswani
    Hareram Birla
    Saumitra Sen Singh
    Hagera Dilnashin
    Surya Pratap Singh
    [J]. Neurotoxicity Research, 2019, 36 : 612 - 626
  • [8] Inflammation and Huntington's disease - a neglected therapeutic target?
    Field, Sophie E.
    Curle, Annabel J.
    Barker, Roger A.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024, 33 (05) : 451 - 467
  • [9] ARE MITOCHONDRIA A POSSIBLE THERAPEUTIC TARGET IN HUNTINGTON'S DISEASE?
    Melone, Marina
    Di Cristo, Francesca
    Digilio, Filomena Anna
    Paladino, Simona
    Valentino, Anna
    Finicelli, Mauro
    Squillaro, Tiziana
    Napolitano, Filomena
    Scialo, Filippo
    Galderisi, Umberto
    Giordano, Antonio
    Peluso, Gianfranco
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 : A92 - A92
  • [10] Quality Control in Huntington's Disease: a Therapeutic Target
    Rai, Sachchida Nand
    Singh, Brijesh Kumar
    Rathore, Aaina Singh
    Zahra, Walia
    Keswani, Chetan
    Birla, Hareram
    Singh, Saumitra Sen
    Dilnashin, Hagera
    Singh, Surya Pratap
    [J]. NEUROTOXICITY RESEARCH, 2019, 36 (03) : 612 - 626